Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study
Open Access
- 13 December 2019
- journal article
- research article
- Published by Springer Nature in Advances in Therapy
- Vol. 37 (2) , 707-717
Abstract
Introduction Diquafosol is a P2Y2 receptor agonist that has been shown to be effective in the treatment of dry eye disease (DED) in short-term studies; however, its long-term safety and effectiveness have not been evaluated in a real-world setting. Methods This prospective, multicentre, open-label observational study was conducted in patients with DED over 12 months. Safety endpoints included the incidence of adverse drug reactions (ADRs) and serious ADRs. Effectiveness endpoints included change from baseline in keratoconjunctival staining score, tear film break-up time (BUT) and Dry Eye-related Quality of Life Score (DEQS). Results A total of 580 patients were included, most of whom were female (82.9%). The proportion of patients who completed 12 months of observation was 55.0%, the most common reason for discontinuation was patient decision (54.6%). The incidence of ADRs was 10.7% and was highest during the first month of treatment (5.5%); no serious ADRs were reported. Compared with baseline, significant improvements in all effectiveness outcomes, including keratoconjunctival fluorescein staining score, BUT and DEQS summary score, were observed at each evaluation during the treatment period (p < 0.001). Conclusion The present, real-world study showed that diquafosol 3.0% ophthalmic solution was well tolerated and effective in the long-term treatment of DED.Keywords
Funding Information
- Santen Pharmaceutical Co., Ltd. (Award Number:NA)
This publication has 15 references indexed in Scilit:
- Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future DirectionsInvestigative Ophthalmology & Visual Science, 2018
- Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and OlderAmerican Journal of Ophthalmology, 2017
- TFOS DEWS II Definition and Classification ReportThe Ocular Surface, 2017
- TFOS DEWS II Diagnostic Methodology reportThe Ocular Surface, 2017
- Importance of Tear Film Instability in Dry Eye Disease in Office Workers Using Visual Display Terminals: The Osaka StudyAmerican Journal of Ophthalmology, 2015
- Development and Validation of the Dry Eye–Related Quality-of-Life Score QuestionnaireJAMA Ophthalmology, 2013
- Prevalence of Dry Eye Disease and its Risk Factors in Visual Display Terminal Users: The Osaka StudyAmerican Journal of Ophthalmology, 2013
- A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patientsBritish Journal of Ophthalmology, 2012
- Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force ReportValue in Health, 2012
- Observational research methods. Research design II: cohort, cross sectional, and case-control studiesEmergency Medicine Journal, 2003